School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Transmedics Group Inc TMDX

Healthcare · Health Care

$77.87last close 2026-10-09 · market cap $2.70B · delayed data

Trailing returns

1M-9.87%
3M+7.87%
6M-28.69%
1Y-31.08%
5Y+184.20%

Basis: Adjusted daily closes.

What it does

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.

Open TMDX in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies